PCM
MRNA icon

Perkins Capital Management’s Moderna MRNA Stock Holding History

Perkins Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$280K Hold
4,000
– – 0.21% 68
2026
Q1 		$203K Buy
+4,000
New +$187K 0.19% 74
2024
Q4 		– Sell
-6,375
Closed -$426K – 85
2024
Q3 		$426K Sell
6,375
-1,000
-14% -$91.8K 0.4% 59
2024
Q2 		$876K Buy
7,375
+3,675
+99% +$465K 0.83% 38
2024
Q1 		$394K Hold
3,700
– – 0.33% 65
2023
Q4 		$368K Buy
+3,700
New +$311K 0.31% 67

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Perkins Capital Management's MRNA Position: Q2 2026 in Review

Perkins Capital Management held its Moderna (MRNA) position steady in Q2 2026 at 4,000 shares worth $280K. The position accounts for 0.21% of the portfolio, ranked #68.

Perkins Capital Management first reported a position in MRNA in Q4 2023 and has held it in 6 quarters since. The position peaked at $876K in Q2 2024. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Perkins Capital Management held 4,000 shares of Moderna worth $280K as of Q2 2026.
  • Perkins Capital Management left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.21% of Perkins Capital Management's portfolio in Q2 2026, its #68 holding.
  • Perkins Capital Management first reported a position in Moderna in Q4 2023 and has held it in 6 quarters since.
  • Perkins Capital Management's Moderna position peaked at $876K in Q2 2024.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.